CDH1 E-cadherin EGF HER2 RARA RPL19 WNT/β-catenin pathway gastric cancer metastasis survival

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
28 Feb 2022
Historique:
received: 28 12 2021
revised: 18 02 2022
accepted: 22 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

Trastuzumab is a human epidermal growth factor receptor 2 (HER2) inhibitor used to treat HER2+ metastatic gastric cancer (mGC). The present study aims to investigate the relationship between

Identifiants

pubmed: 35267574
pii: cancers14051266
doi: 10.3390/cancers14051266
pmc: PMC8909509
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : 5X1000
ID : 5X1000_2010_MdS funding

Références

Nat Cell Biol. 2006 Dec;8(12):1398-406
pubmed: 17072303
J Biol Chem. 2009 Oct 2;284(40):27327-35
pubmed: 19654330
J Cell Biochem. 2018 Sep 11;:
pubmed: 30206979
Trends Pharmacol Sci. 2018 Jul;39(7):648-658
pubmed: 29678298
J Cell Biol. 2005 Jan 3;168(1):29-33
pubmed: 15631989
Annu Rev Pathol. 2011;6:345-64
pubmed: 21073338
Oncology. 2019;97(5):311-318
pubmed: 31550723
Cancer Immunol Immunother. 2014 Jun;63(6):581-6
pubmed: 24668364
Int J Mol Sci. 2021 Jul 20;22(14):
pubmed: 34299349
Nat Commun. 2016 Jun 06;7:11390
pubmed: 27265389
Front Immunol. 2019 Sep 26;10:2293
pubmed: 31616443
Genes (Basel). 2018 Mar 23;9(4):
pubmed: 29570681
Nat Commun. 2017 May 30;8:15622
pubmed: 28555645
Sci Rep. 2018 Jan 25;8(1):1595
pubmed: 29371630
Oncol Rep. 2014 Jul;32(1):45-9
pubmed: 24841138
Cell Mol Gastroenterol Hepatol. 2019;8(1):119-142
pubmed: 30910700
Cell Signal. 2021 Mar;79:109885
pubmed: 33340661
Cell Signal. 2012 Feb;24(2):532-538
pubmed: 22024284
Mol Cell Biol. 2004 Jan;24(1):306-19
pubmed: 14673164
Cancer Manag Res. 2019 Dec 13;11:10477-10486
pubmed: 31853199
Gastric Cancer. 2016 Oct;19(4):1095-1103
pubmed: 26581547
Mol Cell Biol. 2001 Jul;21(13):4246-55
pubmed: 11390653
Oncogene. 2019 Jan;38(5):747-764
pubmed: 30177836
Cell. 2016 Nov 17;167(5):1241-1251.e11
pubmed: 27839865
Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16
pubmed: 16829981
Biomed Res Int. 2014;2014:408047
pubmed: 25535613
Cell Biosci. 2014 Mar 04;4(1):13
pubmed: 24594309
Invasion Metastasis. 1998;18(1):44-56
pubmed: 10207250
Genes Cancer. 2011 Apr;2(4):392-403
pubmed: 21779508
Int J Mol Sci. 2018 Jun 06;19(6):
pubmed: 29882766
Mol Cancer Ther. 2019 Nov;18(11):2135-2145
pubmed: 31484705
Int J Mol Sci. 2018 Jul 06;19(7):
pubmed: 29986466
Mol Cell. 2014 Feb 6;53(3):444-57
pubmed: 24412065
Oncol Rep. 2021 Aug;46(2):
pubmed: 34278502
J Biol Chem. 2010 Oct 8;285(41):31164-73
pubmed: 20693288
Cancer Cell. 2003 Dec;4(6):499-515
pubmed: 14706341
J Biol Chem. 2008 Jun 27;283(26):18393-401
pubmed: 18434311
Mol Cancer. 2010 Sep 09;9:236
pubmed: 20828404
Br J Cancer. 1999 Dec;81(8):1392-7
pubmed: 10604738
Gastric Cancer. 2015 Jul;18(3):476-84
pubmed: 25038874
Pharmacol Ther. 2019 Sep;201:103-119
pubmed: 31028837
J Biol Chem. 2008 Feb 22;283(8):5127-37
pubmed: 18057010
FASEB J. 2017 Nov;31(11):4832-4844
pubmed: 28733458
Oncogene. 2016 Mar 31;35(13):1619-31
pubmed: 26189796
World J Exp Med. 2015 May 20;5(2):84-102
pubmed: 25992323
Oncol Rev. 2018 May 16;12(1):355
pubmed: 30057690
Lancet. 2020 Aug 29;396(10251):635-648
pubmed: 32861308
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Cell Death Dis. 2021 Feb 19;12(2):202
pubmed: 33608512
J Biol Chem. 1997 Nov 28;272(48):30185-90
pubmed: 9374500
J Clin Oncol. 2019 Oct 10;37(29):2610-2619
pubmed: 31430226
Mol Carcinog. 2014 Nov;53(11):893-906
pubmed: 23776059
Cancer Res. 2021 Dec 1;81(23):5800-5802
pubmed: 34853039
Sci Signal. 2011 Nov 01;4(197):ra71
pubmed: 22045851
Science. 2004 Mar 5;303(5663):1483-7
pubmed: 15001769
Dev Growth Differ. 2021 Apr;63(3):199-218
pubmed: 33619734
Int J Mol Sci. 2017 Dec 23;19(1):
pubmed: 29295527
Cold Spring Harb Perspect Med. 2016 May 02;6(5):
pubmed: 27048304
Biochim Biophys Acta Gene Regul Mech. 2018 Mar;1861(3):258-270
pubmed: 29466696
Trends Cell Biol. 2016 Dec;26(12):956-967
pubmed: 27568239
Mol Cell. 2009 Nov 25;36(4):547-59
pubmed: 19941816
Biomed Res Int. 2014;2014:637308
pubmed: 25184143
Stem Cells. 2014 Aug;32(8):2061-71
pubmed: 24648413
Cancer Res. 2013 Jul 15;73(14):4474-87
pubmed: 23720052
J Clin Oncol. 2020 Sep 20;38(27):3138-3149
pubmed: 32678716
Mol Biol Cell. 2016 Nov 1;27(21):3233-3244
pubmed: 27582386

Auteurs

Valli De Re (V)

Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Lara Alessandrini (L)

Surgical Pathology and Cytopathology Unit, Department of Medicine (DIMED), University of Padova, 35128 Padova, Italy.

Giulia Brisotto (G)

Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Laura Caggiari (L)

Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Mariangela De Zorzi (M)

Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Mariateresa Casarotto (M)

Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Gianmaria Miolo (G)

Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Fabio Puglisi (F)

Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.

Silvio Ken Garattini (SK)

Department of Oncology, University Hospital, 33100 Udine, Italy.

Sara Lonardi (S)

Oncology Unit 3, Veneto Institute of Oncology, Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), 35128 Padova, Italy.

Renato Cannizzaro (R)

Oncological Gastroenterology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Vincenzo Canzonieri (V)

Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Department of Medical, Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy.

Matteo Fassan (M)

Surgical Pathology and Cytopathology Unit, Department of Medicine (DIMED), University of Padova, 35128 Padova, Italy.
Oncology Unit 3, Veneto Institute of Oncology, Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), 35128 Padova, Italy.

Agostino Steffan (A)

Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Classifications MeSH